Active Ingredient: Hyaluronic Acid (24 mg/mL)

Anesthetic: 0.3% Lidocaine

Technology: 3D Matrix Cross-linking

Volume: 2 × 1.0 mL pre-filled

Origin: Allergan Aesthetics

Duration of Effect: 9 to 12 months post-treatment

Patient Satisfaction: 92% continuous improvement at 6 months

Adverse Event Rate: ≤2.8% (mild, transient injection site reactions)

Target Areas: Nasolabial folds, marionette lines, chin contour

Standardized Injection Protocol

Temperature: Store between 2°C and 25°C

Conditions: Do not freeze. Protect from direct sunlight.

Shelf Life: 24 months from manufacturing date

Disposal: Single-use medical device. Discard immediately after initial opening.

Certifications: clinically established, EMA Compliant Medical Device (Class III)

Contraindications: Patients with severe multiple allergies, history of anaphylaxis, or gram-positive bacterial protein hypersensitivity.

Administration Restriction: Distribution and injection strictly limited to licensed, trained medical practitioners. Unapproved administration violates clinical safety guidelines.